Literature DB >> 3763406

Chromatin structure of the promoter region of the human c-K-ras gene.

J Jordano, M Perucho.   

Abstract

The chromatin structure of the human c-K-ras gene has been investigated in various cultured normal and tumor human cells and in a rat cell line transformed with the human oncogene. The promoter region is hypersensitive to DNAse I, micrococcal nuclease, endogenous nucleases and to S1 nuclease in supercoiled plasmids. This hypersensitive region is present in the different cell types analyzed and both normal and mutant alleles exhibit similar general sensitivity to DNAse I digestion in the same tumor cells. However, the 5' more distal DNAse I hypersensitive site, which is coincident with a region of the gene containing sequence homologies with known enhancers, exhibits variable sensitivity which appears to be higher in the tumor than in the normal and in the human than in the rat cells which we have analyzed. These data suggest the presence of specific factors interacting with the promoter sequences and delimits the transcription unit of the c-K-ras locus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3763406      PMCID: PMC311756          DOI: 10.1093/nar/14.18.7361

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  A 200 base pair region at the 5' end of the chicken adult beta-globin gene is accessible to nuclease digestion.

Authors:  J D McGhee; W I Wood; M Dolan; J D Engel; G Felsenfeld
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

2.  In vivo sequence requirements of the SV40 early promotor region.

Authors:  C Benoist; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

3.  Genetic and physical linkage of exogenous sequences in transformed cells.

Authors:  M Perucho; D Hanahan; M Wigler
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  The 5' ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I.

Authors:  C Wu
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

5.  Isolation of the chicken thymidine kinase gene by plasmid rescue.

Authors:  M Perucho; D Hanahan; L Lipsich; M Wigler
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

6.  Sequence specific cleavage of DNA by micrococcal nuclease.

Authors:  W Hörz; W Altenburger
Journal:  Nucleic Acids Res       Date:  1981-06-25       Impact factor: 16.971

7.  Normal rat cell lines deficient in nuclear thymidine kinase.

Authors:  W C Topp
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

8.  Oncogene amplification during tumorigenesis of established rat fibroblasts reversibly transformed by activated human ras oncogenes.

Authors:  E Winter; M Perucho
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

9.  The changes in proviral chromatin that accompany morphological variation in avian sarcoma virus-infected rat cells.

Authors:  D J Chiswell; D A Gillespie; J A Wyke
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

10.  Micrococcal nuclease as a probe of DNA sequence organization and chromatin structure.

Authors:  M A Keene; S C Elgin
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

View more
  14 in total

1.  Conformation and expression of the albumin gene of young and old rats.

Authors:  A Singh; S Singh; M S Kanungo
Journal:  Mol Biol Rep       Date:  1990-11       Impact factor: 2.316

2.  High-resolution three-dimensional NMR structure of the KRAS proto-oncogene promoter reveals key features of a G-quadruplex involved in transcriptional regulation.

Authors:  Abdelaziz Kerkour; Julien Marquevielle; Stefaniia Ivashchenko; Liliya A Yatsunyk; Jean-Louis Mergny; Gilmar F Salgado
Journal:  J Biol Chem       Date:  2017-03-22       Impact factor: 5.157

3.  DNase I- and micrococcal nuclease-hypersensitive sites in the human apolipoprotein B gene are tissue specific.

Authors:  B Levy-Wilson; C Fortier; B D Blackhart; B J McCarthy
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

4.  Isolation and characterization of the human Gs alpha gene.

Authors:  T Kozasa; H Itoh; T Tsukamoto; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Insight into the Complexity of the i-Motif and G-Quadruplex DNA Structures Formed in the KRAS Promoter and Subsequent Drug-Induced Gene Repression.

Authors:  Christine E Kaiser; Natalie A Van Ert; Prashansa Agrawal; Reena Chawla; Danzhou Yang; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2017-06-15       Impact factor: 15.419

6.  G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription.

Authors:  Susanna Cogoi; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2006-05-10       Impact factor: 16.971

Review 7.  G-quadruplexes in viruses: function and potential therapeutic applications.

Authors:  Mathieu Métifiot; Samir Amrane; Simon Litvak; Marie-Line Andreola
Journal:  Nucleic Acids Res       Date:  2014-10-20       Impact factor: 16.971

8.  MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.

Authors:  Susanna Cogoi; Sonia Zorzet; Valentina Rapozzi; Imrich Géci; Erik B Pedersen; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2013-03-06       Impact factor: 16.971

9.  Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins.

Authors:  Susanna Cogoi; Manikandan Paramasivam; Barbara Spolaore; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2008-05-19       Impact factor: 16.971

10.  Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.

Authors:  Manikandan Paramasivam; Susanna Cogoi; Vyacheslav V Filichev; Niels Bomholt; Erik B Pedersen; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2008-05-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.